TrialJournal of cosmetic dermatology2026

Patient-Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose-Ranging Study.

Shannon Humphrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.